Newly approved drug heralded as ‘game changer’ in the growing national obesity crisis
(NEW YORK) -- A new weight-loss treatment is being heralded by some health experts as "groundbreaking," and a potential "game changer" in the growing epidemic of obesity.
Semaglutide, an injectable drug made by the pharmaceutical company Novo Nordisk, was approved Friday by the Food and... Read More.
